
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) was raised to Overweight from Equal Weight with a $211 price target (versus a $157.82 prior close) at Morgan Stanley.
American International Group Inc. (NYSE: AIG) was downgraded to Market Perform from Outperform and the price target was cut to $63 from $68 (versus a $56.92 close) at FBR Capital Markets.
BlackRock Inc. (NYSE: BLK) was raised to Buy from Neutral with a $350 price target (versus a $295.92 close) at UBS.
Facebook Inc. (NASDAQ: FB) was started as Outperform with a $115 price target (versus a $90.95 close) at Wedbush Securities.
Finish Line Inc. (NASDAQ: FINL) was raised to Neutral from Sell at Goldman Sachs. Finish Line closed most recently at $18.92.
ALSO READ: 4 Blue Chip High-Dividend Energy Stocks on Sale After Market Sell-Off
Fifth Third Bancorp (NASDAQ: FITB) was downgraded to Neutral from at Goldman Sachs.
Gilead Sciences Inc. (NASDAQ: GILD) was downgraded to Equal Weight from Overweight at Morgan Stanley.
Google Inc. (NASDAQ: GOOG) was raised to Outperform from Perform with a $700 price target (versus a $611.29 close) at Oppenheimer.
Horsehead Holding Corp. (NASDAQ: ZINC) was downgraded to Perform from Outperform at Oppenheimer.
LPL Financial Holdings Inc. (NASDAQ: LPLA) was downgraded to Sell from Neutral with a $36 price target (versus a $39.39 close) at UBS.
Martin Marietta Materials Inc. (NYSE: MLM) was raised to Buy from Neutral at Longbow Research.
Northern Trust Corp. (NASDAQ: NTRS) was raised to Neutral from Sell with a $70 price target (versus a $68.21 close) at UBS.
Old Dominion Freight Line Inc. (NASDAQ: ODFL) was started as Buy at Bank of America Merrill Lynch.
Ollie’s Bargain Outlet Holdings Inc. (OLLI) was raised to Outperform from Neutral with a $20 price target (versus a $16.08 close) at Credit Suisse.
ALSO READ: Groundbreaking Technology Innovation Could Be Huge for 5 Top Tech Stocks
Radius Health Inc. (NASDAQ: RDUS) was started as Overweight with a price target of $88 (versus a $74.57 close) at JPMorgan.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was downgraded to Equal Weight from Overweight at Morgan Stanley.
Ryanair Holdings PLC (NASDAQ: RYAAY) was downgraded to Hold from Buy at HSBC.
T. Rowe Price Group Inc. (NASDAQ: TROW) was downgraded to Neutral from Buy at UBS.
Twitter Inc. (NYSE: TWTR) was started as Neutral with a $30 price target (versus a $24.68 close) at Wedbush Securities.
Valeant Pharmaceuticals International Inc. (NYSE: VRX) was downgraded to Equal Weight from Overweight at Morgan Stanley.
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) to Overweight from Equal Weight with a $148 price target (versus a $107.23 close) at Morgan Stanley.
In case you missed Thursday’s top analyst upgrades and downgrades, they were in shares of AGCO, Celgene, Devon Energy, JD.com, Microsoft, SanDisk, Crocs, Illumina and over a dozen more companies.
ALSO READ: 5 High-Dividend Blue Chip Stocks on Sale After Market Sell-Off